Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -623 | -1,598 | -1,250 | 95 | -104 |
| Depreciation Amortization | 40 | 153 | 110 | 61 | 30 |
| Accounts receivable | -113 | 148 | 151 | -3 | -113 |
| Accounts payable and accrued liabilities | -318 | 204 | -258 | -458 | 55 |
| Other Working Capital | -311 | 115 | -323 | -322 | 4 |
| Other Operating Activity | 500 | -1,116 | -742 | -82 | 90 |
| Operating Cash Flow | $-824 | $-2,093 | $-2,313 | $-709 | $-37 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -227 | -223 | -24 | -22 |
| Purchase Of Investment | N/A | -493 | -486 | -265 | -174 |
| Sale Of Investment | N/A | 1,069 | 495 | 298 | 211 |
| Other Investing Activity | -7 | 69 | 78 | 58 | -12 |
| Investing Cash Flow | $-16 | $418 | $-136 | $67 | $4 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1 | 4 | 146 | 202 | 27 |
| Financing Cash Flow | $-1 | $4 | $146 | $202 | $27 |
| Exchange Rate Effect | 43 | 40 | 450 | -115 | -72 |
| Beginning Cash Position | 2,887 | 4,518 | 4,518 | 4,518 | 4,518 |
| End Cash Position | 2,089 | 2,887 | 2,665 | 3,962 | 4,439 |
| Net Cash Flow | $-798 | $-1,631 | $-1,852 | $-556 | $-79 |
| Free Cash Flow | |||||
| Operating Cash Flow | -824 | -2,093 | -2,313 | -709 | -37 |
| Capital Expenditure | -9 | -227 | -223 | -24 | -22 |
| Free Cash Flow | -833 | -2,320 | -2,536 | -733 | -59 |